Carregant...
Rheumatic complications in cancer patients treated with immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) have revolutionized anticancer therapy due to their long-term clinical benefits and immune boosting mechanisms. However, despite their consistent therapeutic effects, the use of ICIs is associated with a spectrum of adverse events due to their autoimmune and auto-...
Guardat en:
| Publicat a: | Korean J Intern Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Korean Association of Internal Medicine
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6823575/ https://ncbi.nlm.nih.gov/pubmed/31014065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2019.060 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|